News
20.10.2023
Scientific and Practical conference «Clinical Neurology: Innovations in diagnosis and treatment»
Pharm&Access team as usual supported the Scientific and Practical conference with international participation
29.09.2023
Republican conference «Management of Neurological Diseases»
Our company had taken part in the Republican conference with international participation «Management of Neurological Diseases» on September 28-29, 2023 in Astana, Kazakhstan.
30.08.2023
School for Spinal Muscular Atrophy Awareness Month and Duchenne Myopathy Awareness Day by «Omirge sen»
It was an honor for us to help and be a part of School for Spinal Muscular Atrophy Awareness Month and Duchenne Myopathy Awareness Day organized by «Omirge sen» public fund.
17.08.2023
New patient enrollment with Golodirsen orphan medicine in Kazakhstan.
Another 1 patient started therapy with Golodirsen in region in Kazakhstan. All exon-skipping therapies in world are available for our patients as well.
01.08.2023
New patient enrollment with Eteplirsen orphan medicine in Kazakhstan.
1 patient started therapy with Eteplirsen in another one region in Kazakhstan.
15.07.2023
Seminar for pediatric neurologists
Another seminar for pediatric neurologists of South Kazakhstan region was organized in order to increase awareness on neuromuscular diseases and diagnostic program (Duchenne muscular dystrophy) and specialists shared knowledge and experience in available treatments.
13.07.2023
Lectures for doctors
A number of lectures for more than 100 doctors (pediatricians, general doctors, pediatric neurologists and heads of the children's department) were conducted aimed to increase awareness on Duchenne muscular dystrophy and diagnostic program of neuromuscular diseases.
31.05.2023
First infusions with Eteplirsen orphan medicine from Qazaqstan Khalqyna fund reimbursement for new DMD patients in Kazakhstan.
2 new patients started therapy with Eteplirsen in June 2023.
31.05.2023
First infusions with Golodirsen orphan medicine from Qazaqstan Khalqyna fund reimbursement for new DMD patients in Kazakhstan.
2 new patients started therapy with Golodirsen in June 2023.
28.04.2023
First infusions with Eteplirsen orphan medicine from Qazaqstan Khalqyna fund reimbursement for DMD patients in Kazakhstan.
Patient started therapy with Eteplirsen. All exonskipping therapies in world are available for our patients.
26.12.2022
The public fund Qazaqstan Khalkyna had delivered a number of medicine to the regions of Kazakhstan.
On the 23rd of December «Impatients N.V.» company and the official distributor "INTERPHARMSERVICE" had delivered the following medicines